Conduit Pharmaceuticals Inc. (CDT : NASDAQ)
Common Stock
$1.45
USD
+1.37 (1807.89%)
Last updated: 2026-09-29
Follow CDT
CDT
Conduit Pharmaceuticals Inc.
WealthAwesomePerformance
1 Day
+1807.89%
1 Week
+918.97%
1 Month
-14.20%
YTD
-79.08%
Key Statistics
Market Cap
$1.12M
52W High
$1778.00
52W Low
$0.13
P/E Ratio
-
50 Day MA
$25.56
200 Day MA
$1404.96
Beta
1.45
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 9/29/2026 | $1.87 | $1.88 | $1.44 | $1.45 | $1.45 | 586,600 |
| 9/28/2026 | $0.07 | $0.08 | $0.07 | $0.08 | $0.08 | 30,487,969 |
| 9/25/2026 | $0.09 | $0.09 | $0.08 | $0.08 | $0.08 | 26,045,200 |
| 9/24/2026 | $0.12 | $0.13 | $0.12 | $0.12 | $0.12 | 7,394,261 |
| 9/23/2026 | $0.14 | $0.14 | $0.13 | $0.13 | $0.13 | 11,650,728 |
| 9/22/2026 | $0.15 | $0.15 | $0.13 | $0.14 | $0.14 | 12,515,539 |
| 9/21/2026 | $0.17 | $0.17 | $0.15 | $0.15 | $0.15 | 4,481,085 |
| 9/18/2026 | $0.16 | $0.18 | $0.16 | $0.17 | $0.17 | 17,954,300 |
| 9/17/2026 | $0.21 | $0.21 | $0.18 | $0.19 | $0.19 | 4,023,345 |
| 9/16/2026 | $0.21 | $0.21 | $0.18 | $0.20 | $0.20 | 4,764,983 |
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CDT's historical volatility
30-Day Vol
919.8%
Annualized
90-Day Vol
614.3%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
US$1.21
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$1.37 | US$0.06 – US$32.64 |
| 60 trading days | US$1.29 | US$0.01 – US$114.50 |
| 90 trading days | US$1.21 | US$0.00 – US$295.82 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Conduit Pharmaceuticals Inc.
CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company's pipeline includes AZD1656, a glucokinase activator that is in Phase II trials for the treatment of autoimmune disorders, including uveitis, Hashimoto's thyroiditis, preterm labor, and renal transplant; AZD5658, which is in Phase I clinical trial for the treatment of Type 2 Diabetes Mellitus; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It also provides treatments for inflammatory disorders, oncology, dermatology, rare diseases and animal health. The company was formerly known as Conduit Pharmaceuticals Inc. and changed its name to CDT Equity Inc. in August 2025. The company was founded in 2019 and is based in Naples, Florida.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-22.83M
- Profit Margin
- 0.00%
- ROE (TTM)
- -69.68%
- EPS (Diluted)
- -1164.80
- Book Value
- 163.36
Classification
- Sector
- Health Care
- Industry
- Life Sciences Tools & Services
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About CDT.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| AGRZ | Agroz Inc. Ordinary Shares | $3.27 | +1630.16% |
| TRUG | Trugolf Inc | $2.96 | +1013.62% |
| ONMD | OneMedNet Corp. | $5.21 | +722.97% |
| BKYI | BIO-key International, Inc. Common Stock | $3.12 | +85.71% |
| DXST | Decent Holding Inc Ordinary Shares | $3.04 | +55.90% |
| SSTI | Shotspotter Inc | $8.21 | +50.09% |
| MSGY | Masonglory Limited Ordinary Shares | $4.44 | +41.85% |
| ARCLR | ARC Group Acquisition I Corp Right | $0.18 | +38.36% |